Abbvie Inc Stock Market Value

ABBV Stock  USD 175.65  0.39  0.22%   
AbbVie's market value is the price at which a share of AbbVie trades on a public exchange. It measures the collective expectations of AbbVie Inc investors about its performance. AbbVie is selling for under 175.65 as of the 30th of January 2025; that is 0.22 percent increase since the beginning of the trading day. The stock's lowest day price was 175.26.
With this module, you can estimate the performance of a buy and hold strategy of AbbVie Inc and determine expected loss or profit from investing in AbbVie over a given investment horizon. Check out AbbVie Correlation, AbbVie Volatility and AbbVie Alpha and Beta module to complement your research on AbbVie.
Symbol

AbbVie Inc Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
6.2
Earnings Share
2.87
Revenue Per Share
31.397
Quarterly Revenue Growth
0.038
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AbbVie 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AbbVie's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AbbVie.
0.00
03/12/2023
No Change 0.00  0.0 
In 1 year 10 months and 22 days
01/30/2025
0.00
If you would invest  0.00  in AbbVie on March 12, 2023 and sell it all today you would earn a total of 0.00 from holding AbbVie Inc or generate 0.0% return on investment in AbbVie over 690 days. AbbVie is related to or competes with Merck, Pfizer, Eli Lilly, Bristol Myers, Johnson Johnson, Amgen, and Gilead Sciences. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide More

AbbVie Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AbbVie's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AbbVie Inc upside and downside potential and time the market with a certain degree of confidence.

AbbVie Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AbbVie's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AbbVie's standard deviation. In reality, there are many statistical measures that can use AbbVie historical prices to predict the future AbbVie's volatility.
Hype
Prediction
LowEstimatedHigh
173.41175.51177.61
Details
Intrinsic
Valuation
LowRealHigh
158.16190.75192.85
Details
Naive
Forecast
LowNextHigh
173.02175.12177.22
Details
29 Analysts
Consensus
LowTargetHigh
184.12202.33224.58
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AbbVie. Your research has to be compared to or analyzed against AbbVie's peers to derive any actionable benefits. When done correctly, AbbVie's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AbbVie Inc.

AbbVie Inc Backtested Returns

AbbVie Inc secures Sharpe Ratio (or Efficiency) of -0.0995, which signifies that the company had a -0.0995 % return per unit of standard deviation over the last 3 months. AbbVie Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AbbVie's mean deviation of 1.23, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AbbVie's returns are expected to increase less than the market. However, during the bear market, the loss of holding AbbVie is expected to be smaller as well. At this point, AbbVie Inc has a negative expected return of -0.21%. Please make sure to confirm AbbVie's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if AbbVie Inc performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.16  

Very weak predictability

AbbVie Inc has very weak predictability. Overlapping area represents the amount of predictability between AbbVie time series from 12th of March 2023 to 20th of February 2024 and 20th of February 2024 to 30th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AbbVie Inc price movement. The serial correlation of 0.16 indicates that over 16.0% of current AbbVie price fluctuation can be explain by its past prices.
Correlation Coefficient0.16
Spearman Rank Test0.11
Residual Average0.0
Price Variance153.52

AbbVie Inc lagged returns against current returns

Autocorrelation, which is AbbVie stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AbbVie's stock expected returns. We can calculate the autocorrelation of AbbVie returns to help us make a trade decision. For example, suppose you find that AbbVie has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

AbbVie regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AbbVie stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AbbVie stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AbbVie stock over time.
   Current vs Lagged Prices   
       Timeline  

AbbVie Lagged Returns

When evaluating AbbVie's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AbbVie stock have on its future price. AbbVie autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AbbVie autocorrelation shows the relationship between AbbVie stock current value and its past values and can show if there is a momentum factor associated with investing in AbbVie Inc.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.